Table 2 Anticoagulation scheme.
Preexisting medication | Intervention | Prolonged anticoagulation after day 3 |
|---|---|---|
NONE (n = 74) | Unfractionated heparin for 3 days | None (n = 54*) |
Fractionated heparin (n = 14) | ||
Prolonged unfractionated heparin (n = 2) | ||
Thrombocyte aggregation inhibitor (n = 2) | ||
Direct Xa inhibitor (n = 1) | ||
Thrombocyte aggregation inhibitor + fractionated heparin (n = 1) | ||
Fractionated heparin (n = 9) | Unfractionated heparin for 3 days | Fractionated heparin (n = 7) |
Prolonged unfractionated heparin (n = 2) | ||
Thrombocyte aggregation inhibitor + fractionated heparin (n = 1) | ||
Thrombocyte aggregation inhibitor (n = 9) | + unfractionated heparin for 3 days | Thrombocyte aggregation inhibitor (n = 7) |
+ fractionated heparin (n = 2) | ||
Thrombocyte aggregation inhibitor + fractionated heparin (n = 1) | Thrombocyte aggregation inhibitor + unfractionated heparin for 3 days | Thrombocyte aggregation inhibitor + fractionated heparin (n = 1) |
Unfractionated heparin (n = 1) | Unfractionated heparin for 3 days | Fractionated heparin (n = 1) |
